Materials and General Methods.
All chemical reagents were purchased from Aldrich Chemical or Acros Organics and used without additional purification unless noted otherwise. Optima grade acetonitrile was obtained from Fisher Scientific and degassed under vacuum prior to HPLC purification of SAM and SeAM analogues. All reactions for the preparation of SAM and SeAM analogues were carried out in capped vials (4 mL) stirred with Teflon®-coated magnetic stir bars. Reaction solvents were removed by a Büchi rotary evaporator equipped with a dry ice-acetone condenser.
Preparative HPLC purification of SAM and SeAM analogues was carried out using a Waters 6000 Controller HPLC/2998 diode array detector with an XBridge Mass spectra were gathered using delayed extraction in a positive ion mode. Desorption was obtained using a 337-nm nitrogen laser with a 3 ns pulse width. C as a crude product prior to further purification using Amberlite® XAD4 resin.
Synthetic Details

Synthesis of α-amino-4-hydroxybutanoic acid (4). L-Methionine
In brief, the crude product was dissolved in 100 mL 0.5 M NaOH and loaded onto arom. H). 
Synthesis and purification of SAM and SeAM analogues (9-14).
A list of activated electrophiles used for the synthesis of SAM and SeAM analogues is presented in Table S1 . These electrophiles were either purchased directly from
Sigma-Aldrich and used without further purification or freshly prepared in house (Table S1) . 3, 4 Briefly, SAH (20 mg, 51,9 μmol) or SeAH 3 (20 mg, 46.3 μmol)
was dissolved in 500 μL 1:1 formic acid and acetic acid. Respective electrophiles (Table S1, ). 
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Allyl-SAM (10b).
Purification by HPLC yielded 9b (retention time = 7.5 min) as a mixture of sulfonium-R,S-epimers as reported previously. 
Enyne-SAM (12b). Purification by HPLC (retention time = 8.1 min) afforded 12b
as a mixture of sulfonium-R,S-epimers with a yield of 30%. 
Hexyne-SAM (13b). Purification by HPLC (retention time = 9.5 min) afforded 13b
as a mixture of sulfonium-R,S-epimers with a yield of 35%. 
Hey-SAM (14b).
Purification by HPLC (retention time = 9.5 min) afforded 14b as a mixture of sulfonium-R,S-epimers with a yield of 35%. 
Allyl-SeAM (10a). Purification by HPLC (retention time = 7.5 min) afforded 10a
as a mixture of sulfonium-R,S-epimers with a yield of 23%. Pentyne-SeAM (11a). Purification by HPLC (retention time = 8.2 min) afforded 11a as a mixture of sulfonium-R,S-epimers with a yield of 12%. 
Enyne-SeAM (12a). Purification by HPLC (retention time = 8.2 min) afforded 12a
as a mixture of sulfonium-R,S-epimers with a yield of 34%. 
Hey-SeAM (14a).
Purification by HPLC (retention time = 9.4 min) yielded 14a as sulfonium-S-epimer with a yield of 23%. 
MALDI-MS Analysis of Methyltransferase Reactions
Enzyme Assays. All enzymes were expressed and purified according to previously reported procedures. [5] [6] [7] [8] For the assays of native G9a, G9a Y1154A, na- where I represents peak intensities for unmodified (alk
and tri-alkylated (alk 3 ) products peptides, etc. Relative transalkylation activities for sulfur and selenium analogues with equivalent R-groups were then compared and categorized for each examined enzyme. These data were summarized in Table S2 . S18 Table S2 . Summary of relative efficiency of transalkylation with SAM analogues versus equivalent SeAM analogues. Degree of transalkylation was defined as the equivalents of alkylation (or cofactor consumption) per unit peptide substrate according to relative peak intensity of MALDI-MS spectra. For instance, if 50% peptide is converted into a mono-alkylated product, the degree of the transalkylation will be "0.5"; if all the peptide is converted into a di-alkylated product, the degree of the transalkylation will be "2.0". The relative efficiency between of SeAM and their equivalent SAM analogues as cofactors were categorized as "=" for 0~0.1 change of the degree of alkylation; "+" or "-" for increase or decrease of 0.1 ~ 0.5 degree of transalkylation, respectively; "+ +" or "-" for increase or decrease of >0.5 degree of transalkylation, respectively; NR for no reaction observed for SeAM or SAM analogues. These values are shown in parentheses as (Sanalogue, Se-analogue). nG9a, nGLP1, nPRMT1 and nPRMT3 stand as native enzymes. S19 Figure S1 . MALDI-MS spectra demonstrating a lack of modification of H3 peptide substrates by cofactor analogues in the absence of methyltransferase. Spectra in the left hand column are derived from reactions containing sulfur-based analogues (red labels); spectra in the right hand column are from the reactions containing selenium-based analogues (green labels). Figure S2 . MALDI-MS spectra demonstrating sulfur and selenium-based cofactor analogue compatibility with native G9a. Spectra in the left hand column are derived from the reactions containing sulfur-based analogues (red labels); spectra in the right hand column are from the reactions containing selenium-based analogues (green labels). Figure S3 . MALDI-MS spectra demonstrating sulfur and selenium-based cofactor analogue compatibility with the G9a Y1154A mutant. Spectra in the left hand column are derived from the reactions containing sulfur-based analogues (red labels), while spectra in the right hand column are from the reactions containing selenium-based analogues (green labels). Figure S4 . MALDI-MS spectra demonstrating sulfur and selenium-based cofactor analogue compatibility with native GLP1. Spectra in the left hand column are derived from the reactions containing sulfur-based analogues (red labels); spectra in the right hand column are from the reactions containing selenium-based analogues (green labels). Figure S5 . MALDI-MS spectra demonstrating sulfur and selenium-based cofactor analogue compatibility with the GLP1 Y1211A mutant. Spectra in the left hand column are derived from the reactions containing sulfur-based analogues (red labels); spectra in the right hand column are from the reactions containing selenium-based analogues (green labels). Figure S6 . MALDI-MS spectra demonstrating a lack of modification of RGG-Biotin peptide substrates by cofactor analogues in the absence of methyltransferase. Spectra in the left hand column are derived from the reactions containing sulfur-based analogues (red labels); spectra in the right hand column are from the reactions containing selenium-based analogues (green labels). Figure S7 . MALDI-MS spectra demonstrating sulfur and selenium-based cofactor analogue compatibility with native PRMT1. Spectra in the left hand column are derived from the reactions containing sulfur-based analogues (red labels); spectra in the right hand column are from the reactions containing selenium-based analogues (green labels). Figure S8 . MALDI-MS spectra demonstrating sulfur and selenium-based cofactor analogue compatibility with the PRMT1 Y39FM48G mutant. Spectra in the left hand column are derived from the reactions containing sulfur-based analogues (red labels); spectra in the right hand column are from the reactions containing selenium-based analogues (green labels).
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Figure S9. MALDI-MS spectra demonstrating sulfur and selenium-based cofactor analogue compatibility with native PRMT3. Spectra in the left hand column are derived from the reactions containing sulfur-based analogues (red labels), while spectra in the right hand column are from the reactions containing selenium-based analogues (green labels).
Figure S10. MALDI-MS spectra demonstrating sulfur and selenium-based cofactor analogue compatibility with the PRMT3 M233G mutant. Spectra in the left hand column are derived from the reactions containing sulfur-based analogues (red labels); spectra in the right hand column are from the reactions containing selenium-based analogues (green labels).
